Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | LDHA | P00338 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | RAB9A | P51151 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.36 |
| ▸ | APP | P05067 | 1/20 | 0.35 |
| ▸ | LTA4H | P09960 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 2/20 | 0.33 |
| ▸ | MAOB | P27338 | 2/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL819491 | 0.78 | CYP2A6 (0.42) | CYP2A6MAPTCA1CA2CA9 | |
| SCHEMBL16506108 | 0.78 | CYP2A6 (0.50) | CYP2A6MAPTMAPK1MEN1RAB9A | |
| SCHEMBL15449526 | 0.72 | MAPK1 (0.42) | CYP2A6MAPTCA1CA2CA9 | |
| SCHEMBL3843978 | 0.71 | MAPT (0.74) | CYP2A6MAPTCA1CA2CA9 | |
| SCHEMBL391385 | 0.71 | MAPT (0.74) | CYP2A6MAPTCA1CA2CA9 | |
| SCHEMBL3842527 | 0.71 | MAPT (0.74) | CYP2A6MAPTCA1CA2CA9 | |
| SCHEMBL2049674 | 0.71 | APP (0.42) | CA1CA2CA9APPLTA4H | |
| SCHEMBL1975575 | 0.71 | IDO1 (0.36) | IDO1 | |
| SCHEMBL5878 | 0.71 | NFE2L2 (0.39) | CA1CA2CA9MEN1RAB9A | |
| SCHEMBL98774 | 0.71 | LMNA (0.47) | CYP2A6MAPTCA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 739 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118027003-A | PROTAC compound, preparation method thereof and application of PROTAC compound as estrogen receptor degradation agent | 山东大学 | 2024-05-14 | — | — | CN | claimed |
| CN-115155640-B | Molybdenum catalyst, catalytic composition and application thereof in preparation of amine compounds | 海南华瑞医药有限公司 | 2023-09-05 | — | — | CN | claimed |
| CN-110483291-B | Synthesis method of (E) -beta-aryl-beta, gamma-unsaturated ester compound | 安阳师范学院 | 2021-09-10 | — | — | CN | claimed |
| EP-3149138-A1 | WATER CLUSTER-DOMINANT BORONIC ACID ALKALI SURFACTANT COMPOSITIONS AND THEIR USE | The Procter & Gamble Company (US) | 2017-04-05 | — | — | EP | claimed |
| US-9233967-B2 | Process for the preparation of sitagliptin and intermediate compounds | CIPLA LIMITED (IN) | 2016-01-12 | — | — | US | claimed |
| WO-2015184209-A1 | WATER CLUSTER-DOMINANT BORONIC ACID ALKALI SURFACTANT COMPOSITIONS AND THEIR USE | THE PROCTER & GAMBLE COMPANY (US) | 2015-12-03 | — | — | WO | claimed |
| US-20150344817-A1 | WATER CLUSTER-DOMINANT BORONIC ACID ALKALI SURFACTANT COMPOSITIONS AND THEIR USE | THE PROCTER & GAMBLE COMPANY | 2015-12-03 | — | — | US | claimed |
| US-20150197523-A1 | PROCESS FOR THE PREPARATION OF SITAGLIPTIN AND INTERMEDIATE COMPOUNDS | CIPLA LIMITED (IN) | 2015-07-16 | — | — | US | claimed |
| EP-2882752-A1 | PROCESS FOR THE PREPARATION OF SITAGLIPTIN AND INTERMEDIATE COMPOUNDS | Cipla Limited (IN) | 2015-06-17 | — | — | EP | claimed |
| US-8921299-B2 | Detergents having acceptable color | THE PROCTER & GAMBLE COMPANY (US) | 2014-12-30 | — | — | US | claimed |
| WO-2014023930-A1 | PROCESS FOR THE PREPARATION OF SITAGLIPTIN AND INTERMEDIATE COMPOUNDS | CIPLA LIMITED (IN) | 2014-02-13 | — | — | WO | claimed |
| WO-1995005081-A1 | BIOCIDAL COMPOSITIONS CONTAINING ORGANOBORON COMPOUNDS | U.S. BORAX INC. (US) | 1995-02-23 | — | — | WO | claimed |
| EP-4743453-A1 | MODULATORS OF MITOCHONDRIAL DNA REPLICATION | Pretzel Therapeutics, Inc. (US) | 2026-05-20 | — | — | EP | disclosed |
| US-20260109708-A1 | COMPOUNDS AND COMPOSITIONS USEFUL AS DEGRADERS OF MK2 KINASE | CELGENE CORP (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260108486-A1 | SYNTHESIS OF PRO-RESOLVING ANALOGS AND COMPOSITIONS THEREFOR | NOCENDRA INC. (US) | 2026-04-23 | — | — | US | disclosed |
| US-20260110139-A1 | CROSS-LINKED POLYVINYL ALCOHOL ADHESIVES | PROCTER & GAMBLE (US) | 2026-04-23 | — | — | US | disclosed |
| US-5294610-A | Staphylococcus; side effect reduction | MERCK & CO. INC. (US) | 1994-03-15 | — | — | US | disclosed |
| EP-0583383-A1 | LIQUID DETERGENTS WITH AN ARYL BORONIC ACID. | PROCTER & GAMBLE (US) | 1994-02-23 | — | — | EP | disclosed |
| WO-1993016195-A1 | CHEMILUMINESCENT ENHANCERS | BRITISH TECHNOLOGY GROUP LTD. (GB) | 1993-08-19 | — | — | WO | disclosed |
| WO-1992019707-A1 | LIQUID DETERGENTS WITH AN ARYL BORONIC ACID | THE PROCTER & GAMBLE COMPANY (US) | 1992-11-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150197523-A1 | PROCESS FOR THE PREPARATION OF SITAGLIPTIN AND INTERMEDIATE COMPOUNDS | DPP4, DPP7, DPP9 | CYP2A6 1069/4885MAPT 1491/4885CA1 471/4885 |
| US-20260108486-A1 | SYNTHESIS OF PRO-RESOLVING ANALOGS AND COMPOSITIONS THEREFOR | ALOX15B, ALOX12, ALOX15 | CYP2A6 245/4885MAPT 4865/4885CA1 3732/4885 |
| US-20260109708-A1 | COMPOUNDS AND COMPOSITIONS USEFUL AS DEGRADERS OF MK2 KINASE | PSME2, MKRN3, RPS6KA2 | CYP2A6 1878/4885MAPT 2763/4885CA1 3266/4885 |
| US-20260110139-A1 | CROSS-LINKED POLYVINYL ALCOHOL ADHESIVES | VCL, PLOD3, ILK | CYP2A6 4303/4885MAPT 1955/4885CA1 727/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.